SSA
LAB icon

Schonfeld Strategic Advisors’s Standard BioTools LAB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,927
Closed -$28.2K – 2237
2024
Q2 		$28.2K Sell
15,927
-1,213,361
-99% -$2.97M ﹤0.01% 1984
2024
Q1 		$3.33M Buy
1,229,288
+1,038,004
+543% +$2.51M 0.02% 796
2023
Q4 		$423K Buy
191,284
+48,284
+34% +$103K ﹤0.01% 1341
2023
Q3 		$415K Buy
+143,000
New +$374K ﹤0.01% 1252
2022
Q3 		– Sell
-24,530
Closed -$39K – 3081
2022
Q2 		$39K Buy
+24,530
New +$60.7K ﹤0.01% 2256
2020
Q4 		– Sell
-210,600
Closed -$1.56M – 1728
2020
Q3 		$1.56M Buy
+210,600
New +$1.45M 0.03% 581
2020
Q2 		– Sell
-26,800
Closed -$68K – 1397
2020
Q1 		$68K Sell
26,800
-95,000
-78% -$312K ﹤0.01% 1035
2019
Q4 		$424K Sell
121,800
-213,400
-64% -$751K 0.01% 819
2019
Q3 		$1.55M Sell
335,200
-261,500
-44% -$2.06M 0.05% 372
2019
Q2 		$7.35M Sell
596,700
-555,900
-48% -$7.08M 0.26% 94
2019
Q1 		$15.3M Buy
1,152,600
+196,900
+21% +$2.08M 0.53% 32
2018
Q4 		$8.24M Buy
955,700
+530,300
+125% +$4.13M 0.32% 76
2018
Q3 		$3.19M Buy
425,400
+125,400
+42% +$891K 0.14% 203
2018
Q2 		$1.79M Buy
300,000
+150,494
+101% +$858K 0.1% 288
2018
Q1 		$873K Buy
+149,506
New +$982K 0.07% 356

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's LAB Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Standard BioTools (LAB) in Q3 2024, closing a stake of 15,927 shares — an estimated $28.2K sold.

Schonfeld Strategic Advisors first reported a position in LAB in Q1 2018 and held it in 15 quarters. The position peaked at $15.3M in Q1 2019. 141 funds tracked by Wall St. Rank hold LAB as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Standard BioTools position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 15,927 Standard BioTools shares in Q3 2024, an estimated $28.2K.
  • Schonfeld Strategic Advisors first reported a position in Standard BioTools in Q1 2018 and held it in 15 quarters.
  • Schonfeld Strategic Advisors's Standard BioTools position peaked at $15.3M in Q1 2019.
  • 141 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.